BRAINSTORM CELL THERAPEUTICS INC. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit: ratio: %
Description: Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary: Brainstorm Cell Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
Brainstorm Cell Therapeutics Inc. Return On Assets for the quarter ending September 30, 2024 was -373 %, a 55.5% decline year-over-year.
Brainstorm Cell Therapeutics Inc. annual Return On Assets for 2023 was -293 %, a 100% decline from 2022.
Brainstorm Cell Therapeutics Inc. annual Return On Assets for 2022 was -146 %, a 131% decline from 2021.
Brainstorm Cell Therapeutics Inc. annual Return On Assets for 2021 was -63.3 %, a 39.7% increase from 2020.

Return On Assets, Annual (%)

Return On Assets, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date
2023	-293	-146	-100%	Jan 1, 2023	Dec 31, 2023
2022	-146	-82.9	-131%	Jan 1, 2022	Dec 31, 2022
2021	-63.3	+41.7	+39.7%	Jan 1, 2021	Dec 31, 2021
2020	-105	+160	+60.4%	Jan 1, 2020	Dec 31, 2020
2019	-265	-165	-164%	Jan 1, 2019	Dec 31, 2019
2018	-101	-50.9	-102%	Jan 1, 2018	Dec 31, 2018
2017	-49.8	-9.49	-23.6%	Jan 1, 2017	Dec 31, 2017
2016	-40.3	+3.13	+7.21%	Jan 1, 2016	Dec 31, 2016
2015	-43.4	+53.8	+55.4%	Jan 1, 2015	Dec 31, 2015
2014	-97.3	+3.32	+3.3%	Jan 1, 2014	Dec 31, 2014
2013	-101	-8.85	-9.65%	Jan 1, 2013	Dec 31, 2013
2012	-91.7			Jan 1, 2012	Dec 31, 2012

Showing 1 to 12 of 12 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.